Less Ads, More Data, More Tools Register for FREE

Pin to quick picksExperian Regulatory News (EXPN)

Share Price Information for Experian (EXPN)

Share Price is delayed by 15 minutes
Get Live Data
2,549.00    -70.00 (-2.67%)
Bid:
2,547.00
Ask:
2,549.00
Spread: 2.00 (0.079%)
Market Cap: £22.76b
EXPN Live PriceLast checked at - London Stock Exchange

Intraday Experian Share Chart

Capital allocation update

30 Jan 2026 07:00

RNS Number : 9984Q
Experian plc
30 January 2026
 

 

news release

 

 

Capital allocation update: launch of US$1bn share repurchase programme

30 January 2026 - Experian, the global data and technology company, today announces the launch of a US$1bn share repurchase programme (the Programme).

We continue to trade strongly underpinned by our strategic execution and we expect to end this financial year in a favourable leverage position. This enables us to continue to invest in the business while also returning excess capital to shareholders.

 

Given this flexibility, we see opportunity to drive additional shareholder value through the introduction of increased share repurchases. Our medium-term financial framework, capital allocation framework and dividend policy are all unchanged.

 

The Experian plc Board has approved the following Programme:

 

· A share repurchase of up to US$1bn to conclude no later than 30 June 2027. The maximum number of shares that may be repurchased is 89,789,942 pursuant to the authority granted at the 2025 AGM.

· The pace and form of the proposed capital return will be subject to market conditions, and the ongoing assessment of the capital needs of the business. The purpose of the Programme is to reduce the number of shares in issue and to meet obligations arising from employee share plans of c.$200m.

· Experian has entered into an engagement with JP Morgan in connection with the first tranche of the Programme, to commence immediately.

 

This announcement contains Inside Information.

Company LEI: 635400RXXHHYT1JTSZ26.

 

Contact:

Experian

Nadia Ridout-Jamieson Investor queries +44 (0)20 3042 4220

Gerry Tschopp, Nick Jones Media queries

 

Teneo

Graeme Wilson and Louise Male +44 (0)20 7353 4200

 

About Experian

Experian is a global data and technology company, powering opportunities for people and businesses around the world. We help to redefine lending practices, uncover and prevent fraud, simplify healthcare, deliver digital marketing solutions, and gain deeper insights into the automotive market, all using our unique combination of data, analytics and software. We also assist millions of people to realise their financial goals and help them to save time and money.

We operate across a range of markets, from financial services to healthcare, automotive, agrifinance, insurance, and many more industry segments.

We invest in talented people and new advanced technologies to unlock the power of data and to innovate. A FTSE 100 Index company listed on the London Stock Exchange (EXPN), we have a team of 25,200 people across 33 countries. Our corporate headquarters are in Dublin, Ireland. Learn more at experianplc.com.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDDZGZMRLKGVZM
Date   Source Headline
7th Aug 20249:34 amRNSDirector/PDMR Shareholding
31st Jul 202410:59 amRNSTotal Voting Rights
23rd Jul 202410:13 amRNSDirector/PDMR Shareholding
17th Jul 202411:15 amRNSResult of AGM
16th Jul 20247:00 amRNSDirectorate Change
16th Jul 20247:00 amRNSTrading update, first quarter
28th Jun 20245:35 pmRNSSecond interim dividend
28th Jun 20243:10 pmRNSTotal Voting Rights
27th Jun 20249:15 amRNSDirector/PDMR Shareholding
17th Jun 20244:00 pmRNSDirector/PDMR Shareholding
12th Jun 202411:30 amRNSDirector/PDMR Shareholding
7th Jun 20241:34 pmRNSAnnual Financial Report
31st May 20244:12 pmRNSTotal Voting Rights
31st May 20249:36 amRNSElections for Second Interim Dividend
23rd May 20245:30 pmRNSHolding(s) in Company
15th May 20241:30 pmRNSShare repurchases
15th May 20247:00 amRNSFull-year financial report
30th Apr 20245:24 pmRNSTransaction in Own Shares
30th Apr 202411:22 amRNSTotal Voting Rights
29th Apr 20245:52 pmRNSTransaction in Own Shares
26th Apr 20245:19 pmRNSTransaction in Own Shares
25th Apr 20245:16 pmRNSTransaction in Own Shares
24th Apr 20245:14 pmRNSTransaction in Own Shares
23rd Apr 20245:28 pmRNSTransaction in Own Shares
22nd Apr 20245:34 pmRNSTransaction in Own Shares
19th Apr 20245:42 pmRNSTransaction in Own Shares
18th Apr 20245:41 pmRNSTransaction in Own Shares
17th Apr 20245:21 pmRNSTransaction in Own Shares
16th Apr 20245:40 pmRNSTransaction in Own Shares
15th Apr 20245:39 pmRNSTransaction in Own Shares
12th Apr 20246:00 pmRNSTransaction in Own Shares
11th Apr 20245:42 pmRNSTransaction in Own Shares
10th Apr 20245:44 pmRNSTransaction in Own Shares
10th Apr 20249:45 amRNSAdditional Listing
9th Apr 20246:04 pmRNSTransaction in Own Shares
8th Apr 20246:14 pmRNSTransaction in Own Shares
8th Apr 20247:54 amRNSShare repurchase programme
4th Apr 20246:00 pmRNSExperian to acquire Illion in ANZ
3rd Apr 20249:30 amRNSDirector/PDMR Shareholding
28th Mar 202411:05 amRNSTotal Voting Rights
21st Mar 202412:15 pmRNSBlock listing Interim Review
20th Mar 20248:47 amRNSAdditional Listing
14th Mar 20242:08 pmRNSAdditional Listing
6th Mar 20249:15 amRNSAdditional Listing
4th Mar 202411:45 amRNSExperian signs new Revolving Credit Facility
29th Feb 202411:30 amRNSTotal Voting Rights
28th Feb 202410:15 amRNSDirector/PDMR Shareholding
28th Feb 20249:15 amRNSAdditional Listing
21st Feb 20249:15 amRNSAdditional Listing
14th Feb 20249:15 amRNSAdditional Listing

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.